Dr. Michael S. Cartwright, MD

Dr. Cartwright practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Cartwright's NPI, 1417987827, was assigned on July 3, 2006. Dr. Cartwright graduated from Wake Forest School of Medicine in 2002. Dr. Cartwright holds North Carolina license 2006-00235.

Dr. Cartwright's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Cartwright's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Cartwright is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cartwright practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cartwright's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cartwright is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Cartwright is licensed in North Carolina.

Dmand AI lists epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, mobility impairment, muscle disease, muscle weakness and neck pain and spine problems among the conditions Dr. Cartwright treats.

CMS data shows 205 Medicare services from Dr. Cartwright across 4 procedure codes in 2024, for 162 Medicare patients. Medicare paid $12,929 for them.

CMS counts 162 Medicare patients who saw Dr. Cartwright in 2024. The largest group is 65 to 74, with 74 patients. 67% of them have high blood pressure, and 66% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cartwright's median patient age at 67, with 45% women.

In 2024, Dr. Cartwright wrote 712 Medicare Part D claims for 106 patients. 77% of them were for generic drugs. CMS names the drug for 515 of them, across 16 drugs with 11 or more claims each, at $3,403,936 in total drug cost. In 2023, CMS named 465 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Cartwright for performance year 2024, reported as part of a group. Dr. Cartwright accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cartwright as offering telehealth.

Dmand AI links 124 papers to Dr. Cartwright, published from 2005 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Ultrasonography, Neural Conduction and Muscle, Skeletal. Dr. Cartwright has published most often in Muscle Nerve. Dr. Cartwright's most frequent co-authors are James Bayard Caress, MD, Andrea J. Boon, MD and David C. Preston, MD.

Dmand AI links Dr. Cartwright to 1 clinical trial. Conditions studied include Spinal Muscular Atrophies of Childhood and Muscular Atrophy, Spinal.

CMS Open Payments shows 75 general payments to Dr. Cartwright from 17 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 63% of the total. Novartis Gene Therapies, Inc. (fka AveXis, Inc.) paid the most, $5,435.

Dmand AI lists 1 award for Dr. Cartwright, most recently CMS Stage 1 EHR in 2012.

Dr. Cartwright graduated from Wake Forest School of Medicine in 2002.

Dr. Cartwright is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.